Grant: CIHR Fellowship
Direct Payment
$150,000.00
Clinical Applications of Modulating HIF Signaling in Early Mesenchymal Progenitors
FY 2010-11
Summary
The functions of bones include providing mechanical support to soft tissues, supporting blood development, and housing the brain and the spinal cord. Cartilage functions to mechanically support bone and skeletal growth and to serve as a cushioning layer, preventing bones from rubbing against each other. Not surprisingly, given these broad range of responsibilities, the loss of proper function of skeletal cells or an inability of these cells to repair themselves results in a wide range of degenerative bone and joint disorders, such as osteoarthritis and osteoporosis.
During development, cells referred to as osteochondroprogenitor cells, have the potential to become either cartilage or bone elements within the skeleton. Surprisingly, little is known about the events that govern this decision making process in adult osteochondroprogenitor cells. Using mouse models, we will determine if over-expression of certain genes within these cells will result in aberrant cell fate decisions, such as the overproduction of either bone or cartilage. We will access the impact of our genetic modifications by observing the skeletal development of these animals, isolating osteochondroprogenitors, and studying their behaviour in cell culture systems. In parallel to these experiments, we will pharmacologically block signaling events discovered in our mouse studies to determine if we can modulate the behaviour of the human cell equivalents using specific chemical inhibitors. Specifically, we seek to determine if we can force osteochondroprogenitor cells to become either bone or cartilage cells. Manipulation of this signaling pathways to control the fate of these cells will be important in not only understanding the fundamental biology of skeletal development, but will also provide potential therapeutic modalities for a wide range of bone pathologies and potentially improve health care for individuals suffering with degenerative bone and joint disorders.
Department
Program
CIHR Fellowship
Recipient
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
214244
Name
Wu Colleen
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Clinical Applications of Modulating HIF Signaling in Early Mesenchymal Progenitors
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Hif Signaling; Hypoxia; Mesenchymal Progenitor Cells; Mouse Modeling; Osteochondroprogenitors; Progenitor Cell Lineage Commitment
Abstract
The functions of bones include providing mechanical support to soft tissues, supporting blood development, and housing the brain and the spinal cord. Cartilage functions to mechanically support bone and skeletal growth and to serve as a cushioning layer, preventing bones from rubbing against each other. Not surprisingly, given these broad range of responsibilities, the loss of proper function of skeletal cells or an inability of these cells to repair themselves results in a wide range of degenerative bone and joint disorders, such as osteoarthritis and osteoporosis.
During development, cells referred to as osteochondroprogenitor cells, have the potential to become either cartilage or bone elements within the skeleton. Surprisingly, little is known about the events that govern this decision making process in adult osteochondroprogenitor cells. Using mouse models, we will determine if over-expression of certain genes within these cells will result in aberrant cell fate decisions, such as the overproduction of either bone or cartilage. We will access the impact of our genetic modifications by observing the skeletal development of these animals, isolating osteochondroprogenitors, and studying their behaviour in cell culture systems. In parallel to these experiments, we will pharmacologically block signaling events discovered in our mouse studies to determine if we can modulate the behaviour of the human cell equivalents using specific chemical inhibitors. Specifically, we seek to determine if we can force osteochondroprogenitor cells to become either bone or cartilage cells. Manipulation of this signaling pathways to control the fate of these cells will be important in not only understanding the fundamental biology of skeletal development, but will also provide potential therapeutic modalities for a wide range of bone pathologies and potentially improve health care for individuals suffering with degenerative bone and joint disorders.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wu, Colleen
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~